LifeMD, Inc.
LFMD
$6.52
$0.0851.32%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 245.56M | 234.01M | 212.45M | 193.06M | 178.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 245.56M | 234.01M | 212.45M | 193.06M | 178.28M |
| Cost of Revenue | 30.52M | 28.11M | 24.07M | 19.99M | 19.76M |
| Gross Profit | 215.05M | 205.90M | 188.39M | 173.06M | 158.52M |
| SG&A Expenses | 197.74M | 195.28M | 187.10M | 176.29M | 163.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 8.89M | 7.95M | 7.92M | 7.01M | 6.60M |
| Total Operating Expenses | 247.60M | 241.44M | 228.60M | 212.39M | 197.50M |
| Operating Income | -2.03M | -7.43M | -16.14M | -19.33M | -19.22M |
| Income Before Tax | -4.49M | -9.76M | -18.33M | -21.52M | -21.56M |
| Income Tax Expenses | 402.00K | 402.00K | 402.00K | 660.50K | 428.00K |
| Earnings from Continuing Operations | -4.90 | -10.16 | -18.73 | -22.19 | -21.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.03M | -565.60K | -153.20K | -322.10K | -1.51M |
| Net Income | -5.93M | -10.73M | -18.88M | -22.51M | -23.50M |
| EBIT | -2.03M | -7.43M | -16.14M | -19.33M | -19.22M |
| EBITDA | -371.10K | -5.86M | -14.67M | -17.97M | -17.96M |
| EPS Basic | -0.21 | -0.33 | -0.54 | -0.64 | -0.70 |
| Normalized Basic EPS | -0.09 | -0.16 | -0.29 | -0.34 | -0.39 |
| EPS Diluted | -0.22 | -0.34 | -0.54 | -0.65 | -0.71 |
| Normalized Diluted EPS | -0.09 | -0.16 | -0.29 | -0.34 | -0.39 |
| Average Basic Shares Outstanding | 171.76M | 168.66M | 164.77M | 159.30M | 151.75M |
| Average Diluted Shares Outstanding | 174.21M | 171.10M | 164.77M | 159.30M | 151.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -52.40% | -28.95% | -16.45% | -13.80% | -13.22% |